Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study

[1]  J. Baron,et al.  Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence—Data from a Randomized Clinical Trial , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[2]  Mark Woodward,et al.  The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence , 2009, International journal of cancer.

[3]  William K K Wu,et al.  Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  Edward Giovannucci,et al.  Cigarette smoking and colorectal cancer incidence and mortality: Systematic review and meta‐analysis , 2009, International journal of cancer.

[5]  Michael M Gottesman,et al.  A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. , 2009, Biochimica et biophysica acta.

[6]  R. Bostick,et al.  Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma , 2009, International Journal of Colorectal Disease.

[7]  K. Overvad,et al.  Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population , 2009, Scandinavian journal of gastroenterology.

[8]  U. Vogel,et al.  The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study , 2009, BMC Medical Genetics.

[9]  U. Vogel,et al.  Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study , 2009, Cancer Causes & Control.

[10]  S. Küry,et al.  Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study , 2008, BMC Cancer.

[11]  S. Gallinger,et al.  Red Meat Intake, Doneness, Polymorphisms in Genes that Encode Carcinogen-Metabolizing Enzymes, and Colorectal Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[12]  K. Hemminki,et al.  A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer. , 2008, Mutation research.

[13]  A. Tjønneland,et al.  Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer. , 2008, Cancer letters.

[14]  Atsushi Ose,et al.  Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds , 2008, Drug Metabolism and Disposition.

[15]  D. Glavač,et al.  Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability. , 2008, Cancer genetics and cytogenetics.

[16]  Joe Palandra,et al.  Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe , 2008, Pharmacogenetics and genomics.

[17]  F. Pierre,et al.  Experimental Evidence , 2020, Vision and Perception.

[18]  T. Tung,et al.  Effects of moderate alcohol consumption on inflammatory biomarkers , 2008, Acta cardiologica.

[19]  Y. Kawai,et al.  Genuine functions of P-glycoprotein (ABCB1). , 2008, Current drug metabolism.

[20]  Kazuya Maeda,et al.  Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. , 2008, Drug metabolism and pharmacokinetics.

[21]  R. Sinha,et al.  A Prospective Study of Red and Processed Meat Intake in Relation to Cancer Risk , 2007, PLoS medicine.

[22]  U. Vogel,et al.  Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. , 2007, Mutation research.

[23]  A. Tjønneland,et al.  Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: A population-based prospective cohort study of 57,053 men and women in Denmark , 2007, Scandinavian journal of public health.

[24]  Per Artursson,et al.  Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.

[25]  W. Tan,et al.  Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. , 2007, Carcinogenesis.

[26]  Shuji Ogino,et al.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.

[27]  L. Tessitore,et al.  P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. , 2007, Cancer research.

[28]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[29]  V. Andersen,et al.  Human intestinal P‐glycoprotein activity estimated by the model substrate digoxin , 2007, Scandinavian journal of clinical and laboratory investigation.

[30]  P. Villiger,et al.  The −308 tumour necrosis factor-α gene polymorphism predicts therapeutic response to TNFα-blockers in rheumatoid arthritis and spondyloarthritis patients , 2007 .

[31]  P. Villiger,et al.  The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. , 2007, Rheumatology.

[32]  G. Hoff,et al.  Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas , 2007, BMC Cancer.

[33]  A. Tjønneland,et al.  Physical activity and risk of colon cancer in a cohort of Danish middle-aged men and women , 2007, European Journal of Epidemiology.

[34]  C. Meisel,et al.  Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers , 2006, European Journal of Clinical Pharmacology.

[35]  K. Slim,et al.  Tobacco Smoking: A Factor of Early Onset of Colorectal Cancer , 2006, Diseases of the colon and rectum.

[36]  G. Szakács,et al.  Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. , 2006, Physiological reviews.

[37]  R. Xu,et al.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.

[38]  S. Bates,et al.  MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. , 2006, Pharmacological reports : PR.

[39]  Chang-Shin Park,et al.  Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans , 2006, Cancer science.

[40]  R. Sinha,et al.  Inflammation-Related Gene Polymorphisms and Colorectal Adenoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[41]  D. Goldstein,et al.  ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. , 2006, Human molecular genetics.

[42]  B. Dastugue,et al.  Drosophila melanogaster P‐glycoprotein: A membrane detoxification system toward polycyclic aromatic hydrocarbon pollutants , 2006, Environmental toxicology and chemistry.

[43]  A. V. van Herwaarden,et al.  Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk. , 2006, Carcinogenesis.

[44]  R. Millikan,et al.  COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States) , 2006, Cancer Causes & Control.

[45]  A. Bottoni,et al.  Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism. , 2005, The Journal of clinical endocrinology and metabolism.

[46]  Andrew D. Johnson,et al.  Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability , 2005, Pharmacogenetics and genomics.

[47]  Alfonso Lampen,et al.  Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. , 2005, Carcinogenesis.

[48]  W. Haefeli,et al.  Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. , 2005, Biochemical pharmacology.

[49]  H. Krum,et al.  To the heart of the matter: coxibs, smoking, and cardiovascular risk. , 2005, Circulation.

[50]  B. Ning,et al.  Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. , 2005, Gastroenterology.

[51]  M. Sanak,et al.  Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma. , 2005, The Journal of allergy and clinical immunology.

[52]  J. Lubiński,et al.  Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients , 2005, European Journal of Clinical Pharmacology.

[53]  S. Cole,et al.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.

[54]  C. Ulrich,et al.  PTGS2 (COX-2) −765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs , 2005, Cancer Epidemiology Biomarkers & Prevention.

[55]  N. Altorki,et al.  Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. , 2005, Cancer research.

[56]  D. Goldstein,et al.  In genetic control of disease, does 'race' matter? , 2004, Nature Genetics.

[57]  J. Kigawa,et al.  Haplotype-Oriented Genetic Analysis and Functional Assessment of Promoter Variants in the MDR1 (ABCB1) Gene , 2004, Journal of Pharmacology and Experimental Therapeutics.

[58]  S. Chanock,et al.  Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. , 2004, Carcinogenesis.

[59]  D. Glavač,et al.  Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis , 2004, Genes and Immunity.

[60]  Y. Sugiyama,et al.  Functional Analysis of SNPs Variants of BCRP/ABCG2 , 2004, Pharmaceutical Research.

[61]  H. Takane,et al.  The MDR1 (ABCB1) Gene Polymorphism and its Clinical Implications , 2004, Clinical pharmacokinetics.

[62]  M. Sanak,et al.  Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. , 2004, The Journal of allergy and clinical immunology.

[63]  D. Cox,et al.  Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer , 2004, British Journal of Cancer.

[64]  H. Kotani,et al.  Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2 , 2004, International journal of cancer.

[65]  P. Adegboyega,et al.  Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts. , 2004, Molecular pharmacology.

[66]  R. Ho,et al.  (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The Role of MDR1 Genetic Polymorphisms in Interindividual Variability in P-glycoprotein Expression and Function , 2004 .

[67]  R. Ho,et al.  The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function. , 2004, Current drug metabolism.

[68]  R. O. Oude Elferink,et al.  ABC of oral bioavailability: transporters as gatekeepers in the gut , 2003, Gut.

[69]  Jos H Beijnen,et al.  The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2003, Cancer research.

[70]  Conrad C. Huang,et al.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. , 2003, Pharmacogenetics.

[71]  K. Nakayama,et al.  Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities. , 2003, Biochemical pharmacology.

[72]  S. Hirohashi,et al.  Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. , 2003, Cancer research.

[73]  M. Abou‐Donia,et al.  A Role for P-Glycoprotein in Environmental Toxicology , 2003, Journal of toxicology and environmental health. Part B, Critical reviews.

[74]  E. Schuetz,et al.  Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. , 2003, Pharmacogenetics.

[75]  A. Sorokin,et al.  Regulation of MDR-1 (P-glycoprotein) by Cyclooxygenase-2* , 2002, The Journal of Biological Chemistry.

[76]  M. Kasuga,et al.  Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. , 2002, Biological & pharmaceutical bulletin.

[77]  Y. Miki,et al.  C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. , 2002, Molecular cancer therapeutics.

[78]  K. Hirsch‐Ernst,et al.  The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures , 2002, Hepatology.

[79]  S. Habib,et al.  Influence of Cigarette Smoking on Prostaglandin Synthesis and Cyclooxygenase-2 Gene Expression in Human Urinary Bladder Cancer , 2002, Cancer investigation.

[80]  Y. Miki,et al.  C 421 A Polymorphism in the Human Breast Cancer Resistance Protein Gene Is Associated with Low Expression of Q 141 K Protein and Low-Level Drug Resistance 1 , 2002 .

[81]  Hermann Brenner,et al.  Effect of alcohol consumption on systemic markers of inflammation , 2001, The Lancet.

[82]  J. Paik,et al.  Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. , 2000, The Journal of biological chemistry.

[83]  U. Brinkmann,et al.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[84]  R. Johnstone,et al.  Multiple physiological functions for multidrug transporter P-glycoprotein? , 2000, Trends in biochemical sciences.

[85]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[86]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[87]  A. Schinkel,et al.  The physiological function of drug-transporting P-glycoproteins. , 1997, Seminars in cancer biology.

[88]  D. de Freitas,et al.  [Alcohol and cancer]. , 1997, Acta medica portuguesa.

[89]  W. Barlow,et al.  Robust variance estimation for the case-cohort design. , 1994, Biometrics.

[90]  A. Tjønneland,et al.  Influence of individually estimated portion size data on the validity of a semiquantitative food frequency questionnaire. , 1992, International journal of epidemiology.

[91]  A. Tjønneland,et al.  Validation of a semiquantitative food frequency questionnaire developed in Denmark. , 1991, International journal of epidemiology.

[92]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[93]  N. Asp,et al.  Determination of total dietary fiber in foods and food products: collaborative study. , 1985, Journal - Association of Official Analytical Chemists.

[94]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.